CareDx, Inc (CDNA) Comparison with companies in other sectors?

CareDx, Inc has a share price of 55.68M. You can analyze CareDx, Inc (CDNA) competitors across different market sectors through stock heatmaps.

What are CDNA's NET and operating margins?

CareDx, Inc (CDNA) operating margin is around 0.14, and net profit margin is approximately 0.17 as of the latest reports.

In what way does CDNA's earnings per share (EPS) trend reflect its financial momentum?

CareDx, Inc (CDNA) EPS is 1.12 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for CareDx, Inc is 11.42, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for CareDx, Inc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for CareDx, Inc like P/E which is 12.04, P/B which is 1.87, and PEG which is 1.05. Compare them with sector averages to evaluate if the stock is priced fairly.

CareDx, Inc

CDNA•NASDAQ

Healthcare

Medical - Diagnostics & Research

$12.79

$-0.05(-0.39%)

Fundamental Analysis of CareDx, Inc (CDNA)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$1.12

P/E Ratio

11.42

ROE

0.18%

Net Margin

0.17%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$712.15M

Shares OutstandingTotal number of shares issued

$55.68M

Book Value/ShareNet worth per share

$6.86

Revenue/ShareAnnual revenue per share

$6.27

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$1.12

Net MarginNet income as percentage of revenue

16.99%

Operating MarginOperating income as percentage of revenue

13.51%

ROEReturn on shareholders' equity

18.17%

ROAReturn on total assets

12.02%

ROCEReturn on capital employed

11.57%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.45

Cash/ShareCash and equivalents per share

$4.18

FCF YieldFree cash flow as percentage of market cap

3.53%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for CDNAFinancial Ratios Analysis details for CDNA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CDNASector Benchmarking details for CDNA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for CareDx, Inc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of CareDx, Inc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account CareDx, Inc's unique business strengths and challenges.

Key Financial Metrics for CareDx, Inc

For CareDx, Inc, essential financial indicators include EPS 1.12, PE 11.42, and ROE 0.18. These key ratios reveal insights into CareDx, Inc's profitability, valuation, and operational health. Understanding these metrics enables you to compare CareDx, Inc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of CareDx, Inc

Metrics like Net Margin 16.99% and ROA 12.02% shed light on how well CareDx, Inc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether CareDx, Inc can sustain its operations and continue growing in the future.

Valuation and Market Position of CareDx, Inc

Using ratios such as P/B Ratio 1.87 and PEG Ratio 1.05, investors can assess whether CareDx, Inc is appropriately valued based on its financials and growth potential. These figures, combined with CareDx, Inc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for CareDx, Inc

Financial health indicators, such as Debt/Equity Ratio 0.08 and Cash Flow $0.45, provide a snapshot of CareDx, Inc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like CareDx, Inc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for CareDx, Inc

Investing in CareDx, Inc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at CareDx, Inc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;